Neoadjuvant Plus Adjuvant Treatment With Cemiplimab in Cutaneaous Squamous Cell Carcinoma
Clinical trial NCT04632433 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04632433
- Sponsor
- Fondazione Melanoma Onlus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-10
- Primary completion
- 2023-02-06
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.